Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/1999
05/27/1999CA2311238A1 Method for unbiased mrna amplification
05/27/1999CA2310624A1 Chimeric pre-activated transcription factors
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310228A1 Attaching substances to micro-organisms
05/27/1999CA2310215A1 Methods and compositions for the treatment of psoriasis
05/27/1999CA2310016A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309927A1 Oligonucleotide synthesis using high boiling point solvents
05/27/1999CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999CA2309886A1 Cellulase produced by actinomycetes and method of producing same
05/27/1999CA2309885A1 Recombinant allergen with reduced enzymatic activity
05/27/1999CA2309880A1 Chimera gene having a light dependent promoter providing tolerance to hppd inhibitors
05/27/1999CA2309835A1 Alphavirus vectors
05/27/1999CA2309826A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999CA2309807A1 Transgenic models of inflammatory disease
05/27/1999CA2309764A1 Cellulase produced by actinomycetes and method for producing same
05/27/1999CA2309763A1 Variable region fusion peptides that form effector complexes in the presence of antigen
05/27/1999CA2309761A1 Th2 cell depletion; compositions; methods
05/27/1999CA2309758A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309757A1 Stress resistance gene
05/27/1999CA2309754A1 Regulation of fungal gene expression
05/27/1999CA2309719A1 Targeted manipulation of genes in plants
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2309387A1 Method and kit for determining severe inflammatory reactions to mosquito bites
05/27/1999CA2309343A1 Toso
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999CA2309336A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same
05/27/1999CA2309000A1 Tc1-based transposon vectors
05/27/1999CA2308571A1 Single-chain bifunctional glycoprotein hormones
05/27/1999CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999CA2307539A1 Improvements relating to protein accumulation
05/27/1999CA2306776A1 Methods for modulating nerve cell function
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2305866A1 A method for directional stable transformation of eukaryotic cells
05/27/1999CA2302644A1 Extended cdnas for secreted proteins
05/27/1999CA2282811A1 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property
05/27/1999CA2277804A1 Production of a lampbrush chromosome
05/26/1999EP0918091A1 A gene called XLIS and the XLIS gene product, called doublecortin and their applications
05/26/1999EP0917591A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
05/26/1999EP0917586A1 Vector for activating the immune system against cells associated to papilloma viruses or sequences thereof
05/26/1999EP0917585A2 Vectors for delivering viral and oncogenic inhibitors
05/26/1999EP0917584A1 Modified tomato mottle geminivirus coat protein gene
05/26/1999EP0917583A2 Maize promoter sequence for leaf- and stalk-preferred gene expression
05/26/1999EP0917582A2 Genomic sequence of rhizobium sp. ngr 234 symbiotic plasmid
05/26/1999EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
05/26/1999EP0917580A1 DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS
05/26/1999EP0917579A1 Vertebrate telomerase genes and proteins and uses thereof
05/26/1999EP0917578A1 NOVEL STRAINS OF $i(ESCHERICHIA COLI), METHODS OF PREPARING THE SAME AND USE THEREOF IN FERMENTATION PROCESSES FOR L-THREONINE PRODUCTION
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917576A1 Anti-herpesviral agents and assays therefor
05/26/1999EP0917575A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection
05/26/1999EP0917574A2 BCL-x$g(g), A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO
05/26/1999EP0917573A2 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917571A1 Agouti-related gene
05/26/1999EP0917570A2 Mhc binding peptide oligomers and methods of use
05/26/1999EP0917569A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
05/26/1999EP0917567A1 Plasminogen activator capable of being activated by thrombin
05/26/1999EP0917566A1 Recombinant blood-coagulation proteases
05/26/1999EP0917564A2 Phosphate starvation-inducible proteins
05/26/1999EP0917563A2 Micro-organism which can desulphurise benzothiophenes
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917536A2 Polynucleotide and its use for modulating a defence response in plants
05/26/1999EP0917535A1 Neuroactive peptide
05/26/1999EP0917471A2 Treatment and diagnosis of infections of gram positive cocci
05/26/1999EP0833835A4 Obesity protein intermediates and their preparation and use
05/26/1999EP0832278A4 Linked linear amplification of nucleic acids
05/26/1999EP0804731B1 Method and apparatus for fabricating microarrays of biological samples
05/26/1999EP0781293A4 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
05/26/1999EP0777412A4 FbLATE PROMOTER
05/26/1999EP0741749B1 Mercury binding polypeptides and nucleotides coding therefor
05/26/1999EP0710296A4 Linked linear amplification of nucleic acids
05/26/1999EP0668910B1 Human neuropeptide y-y1 receptor
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
05/26/1999EP0453560B1 Localization and characterization of the wilms' tumor gene
05/26/1999CN1217751A Parapoxvirus vectors
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217749A DNA fragments containing biotin biosynthesizing gene and use of same
05/26/1999CN1217748A Transferrin receptor genes of moraxella
05/26/1999CN1217746A Pluripotent rabbit embryonic stem (ES) cell lines and their use in generation of chimeric rabbits
05/26/1999CN1217724A Recombination preparation of calcitonia fragments and use thereof in preparation of same and the like
05/26/1999CN1217632A Method of protein production using mitochondrial translation system
05/26/1999CN1217384A Method for breeding quick-growth transgenosis animals
05/26/1999CN1217342A Colony stimulating factor for recombination of human granulocytes and medicinal composition thereof
05/26/1999CN1217339A Cellulose binding domain
05/26/1999CN1217335A Method for preparing precursor medicine
05/26/1999CA2224845A1 Improved forages
05/25/1999US5907086 Plant promoter sequences
05/25/1999US5907085 Grapevine leafroll virus proteins and their uses
05/25/1999US5907084 Virus resistant or tolerant cells
05/25/1999US5907083 Brassica sp. gene promoter highly expressed during stigma development
05/25/1999US5907082 Ovule-specific gene expression
05/25/1999US5907081 Control of plant abscission and pod dehiscence
05/25/1999US5907080 Method for development of transgenic dwarf goats
05/25/1999US5907079 MSH2 disrupted mice develop lymphomas
05/25/1999US5907078 In vivo model systems that adequately reproduce the spectrum of benign, latent, aggressive and metastatic forms of the human disease.
05/25/1999US5907034 With same affinity to ethylenediamine tetraacetic acid and diethylenetriamine pentaacetic acid as to their complexes with manganese, cadmium, zinc, copper, yttrium, or lead